ADXN NASDAQ
Addex Therapeutics Ltd
1W: -15.9%
1M: -12.8%
3M: -47.0%
YTD: -62.0%
1Y: -67.3%
3Y: -56.4%
5Y: -98.4%
$3.07
+0.09 (+3.02%)
Weekly Expected Move ±14.6%
$2
$3
$3
$4
$4
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$11M
+130.0% ▲
5Y CAGR: -20.2%
Total Liabilities
$1M
-71.4% ▼
5Y CAGR: -33.2%
Shareholders Equity
$10M
+744.8% ▲
5Y CAGR: -17.6%
Cash & Investments
$3M
-13.4% ▼
5Y CAGR: -36.1%
Total Debt
$42K
-87.8% ▼
5Y CAGR: -40.2%
Net Debt
-$3M
+6.3% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $19M | $20M | $7M | $4M | $3M |
| Short-Term Investments | $65K | $17K | $3K | $848 | $6K |
| Cash & ST Investments | $19M | $21M | $7M | $4M | $3M |
| Net Receivables | $68K | $324K | $598K | $151K | $16K |
| Inventory | $163K | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 | $0 | $8K |
| Total Current Assets | $19M | $22M | $8M | $4M | $4M |
| Property, Plant & Equip. | $633K | $542K | $399K | $353K | $43K |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $7M |
| Other Non-Current Assets | $59K | $58K | $54K | $54K | $7K |
| Total Non-Current Assets | $692K | $600K | $453K | $407K | $7M |
| Total Assets | $20M | $23M | $8M | $5M | $11M |
| — Liabilities — | |||||
| Accounts Payable | $984K | $2M | $1M | $984K | $253K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Deferred Revenue | $820K | $0 | $0 | $235K | $0 |
| Other Current Liabilities | $0 | $0 | $0 | $0 | $0 |
| Total Current Liabilities | $4M | $4M | $3M | $3M | $802K |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $2M | $1M | $0 | $444K | $164K |
| Total Non-Current Liabilities | $2M | $1M | $87K | $603K | $199K |
| Total Liabilities | $6M | $6M | $3M | $3M | $1M |
| — Equity — | |||||
| Common Stock | $33M | $49M | $1M | $2M | $2M |
| Retained Earnings | -$314M | -$329M | -$350M | -$360M | -$353M |
| Accumulated OCI | $15M | $24M | $26M | $30M | $31M |
| Total Stockholders Equity | $15M | $17M | $5M | $1M | $10M |
| Total Liabilities & Equity | $20M | $23M | $8M | $5M | $11M |
| — Key Metrics — | |||||
| Total Debt | $567K | $482K | $373K | $344K | $42K |
| Net Debt | -$18M | -$20M | -$7M | -$4M | -$3M |
| Total Investments | $65K | $17K | $3K | $848 | $7M |